1. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, Wieslander J, Kashtan C, Borza DB, Neilson EG, Wilson CB, Hudson BG (2010) N Engl J Med 363(4): 343-54
    › Primary publication · 20660402 (PubMed) · PMC4144421 (PubMed Central)
  2. Models of chronic kidney disease. Yang HC, Zuo Y, Fogo AB (2010) Drug Discov Today Dis Models 7(1-2): 13-19
    › Primary publication · 21286234 (PubMed) · PMC3030258 (PubMed Central)
  3. 'Idiopathic' FSGS: an increasingly obsolete diagnosis? Yang HC, Fogo AB (2010) Nephrol Dial Transplant 25(3): 654-6
    › Primary publication · 20083472 (PubMed)
  4. CKD in Aboriginal Australians. Hoy WE, Kincaid-Smith P, Hughson MD, Fogo AB, Sinniah R, Dowling J, Samuel T, Mott SA, Douglas-Denton RN, Bertram JF (2010) Am J Kidney Dis 56(5): 983-93
    › Primary publication · 20728257 (PubMed)
  5. Cell senescence in the aging kidney. Yang H, Fogo AB (2010) J Am Soc Nephrol 21(9): 1436-9
    › Primary publication · 20705707 (PubMed)
  6. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis. Naito T, Ma LJ, Yang H, Zuo Y, Tang Y, Han JY, Kon V, Fogo AB (2010) Am J Physiol Renal Physiol 298(3): F683-91
    › Primary publication · 20042458 (PubMed) · PMC2838584 (PubMed Central)
  7. Angiotensin receptor blocker protection against podocyte-induced sclerosis is podocyte angiotensin II type 1 receptor-independent. Matsusaka T, Asano T, Niimura F, Kinomura M, Shimizu A, Shintani A, Pastan I, Fogo AB, Ichikawa I (2010) Hypertension 55(4): 967-73
    › Primary publication · 20142565 (PubMed) · PMC2887658 (PubMed Central)
  8. The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury. Yang HC, Deleuze S, Zuo Y, Potthoff SA, Ma LJ, Fogo AB (2009) J Am Soc Nephrol 20(11): 2380-8
    › Primary publication · 19797472 (PubMed) · PMC2799181 (PubMed Central)
  9. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) Kidney Int 76(5): 534-45
    › Primary publication · 19571791 (PubMed)
  10. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D'Agati V, D'Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) Kidney Int 76(5): 546-56
    › Primary publication · 19571790 (PubMed)